LA JOLLA, Calif., Sept. 17, 2020 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company developing itolizumab to treat severe autoimmune and inflammatory disorders, ...
Examining the reliability of surrogate tissue predictability of drug efficacy in reconstituted human 3D skin models containing melanomas. A comparative study of a monoclonal antibody against EGFR ...
This study is the first to focus on ALCAM expression and its prognostic value in breast carcinoma. Normal ductal epithelial cells in breast tissue showed positivity to ALCAM in immunohistochemical ...
Please provide your email address to receive an email when new articles are posted on . Uncovering a viable biomarker in a historically challenging disease like lupus nephritis is tantamount to ...
LA JOLLA, Calif.--(BUSINESS WIRE)-- Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company focused on developing novel therapeutics to treat severe autoimmune and inflammatory disorders ...
Over 77,000 Canadians are living with multiple sclerosis, a disease whose causes still remain unknown. Presently, they have no hope for a cure. In a study published in Science Translational Medicine, ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results